An Open Label pH Comparison of Esomeprazole and Lansoprazole in Barrett's Esophagus Patients

NCT00352261 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

80

Enrollment

INDUSTRY

Sponsor class

Conditions

Barrett's Esophagus

Interventions

DRUG: Esomeprazole
DRUG: Lansoprazole

Sponsor

AstraZeneca